BioCentury
ARTICLE | Company News

Alpha 1 Biomedicals, Cel-Sci deal

September 25, 1995 7:00 AM UTC

CELI will purchase ALBM's 50 percent stake in Viral Technologies Inc., a 50/50 joint venture formed in 1986 to develop the HGP-30 peptide to treat AIDS, for 159,170 shares of CELI stock. CELI (Alexandria, Va.), which has 4.1 million shares outstanding prior to the issuance, closed at $4.938 on Friday. ...